Are There 3 Different Types of ADHD? Brain Scans Say Yes
Why It Matters
Identifying biologically distinct ADHD subtypes enables more precise diagnoses and personalized treatments, potentially improving outcomes and reducing costly medication mismatches.
Key Takeaways
- •Brain scans reveal three biologically distinct ADHD subtypes.
- •Subtype patterns align with clinical combined, hyperactive‑impulsive, inattentive categories.
- •Hyperactive‑impulsive kids show altered impulse‑control brain regions significantly.
- •Inattentive kids exhibit differences in focus‑related neural circuits.
- •Combined type shows greatest abnormalities, especially in mood‑regulation areas.
Summary
Scientists have used magnetic resonance imaging to examine the brains of nearly 450 children diagnosed with attention‑deficit/hyperactivity disorder, uncovering three neurobiologically distinct subtypes. The patterns correspond closely to the three categories already used in the DSM—combined, predominantly hyperactive‑impulsive, and predominantly inattentive—providing the first large‑scale biological validation of the clinical taxonomy.
The study found that children classified as hyperactive‑impulsive displayed reduced connectivity in regions governing impulse control, such as the ventral striatum and prefrontal cortex. In contrast, the inattentive group showed altered activity in networks linked to sustained attention, notably the dorsal attention system. The combined subtype exhibited the most extensive deviations, with pronounced abnormalities in limbic structures tied to emotional regulation, suggesting a neurobiological basis for the heightened mood‑related symptoms observed in this group.
Lead researcher Dr. Emily Chen emphasized that “the presence of distinct neural signatures confirms ADHD is not a monolithic disorder but a spectrum of brain‑based conditions.” The findings echo earlier clinical observations that emotional dysregulation is more prevalent in the combined type, now backed by imaging evidence. The researchers also noted that the three clusters emerged without pre‑imposed labels, underscoring the robustness of the data.
These results could reshape diagnostic protocols and pave the way for personalized treatment strategies, from targeted pharmacotherapy to tailored behavioral interventions. By aligning therapeutic choices with a child’s specific neural profile, clinicians may improve efficacy and reduce trial‑and‑error prescribing, a long‑standing challenge in ADHD care.
Comments
Want to join the conversation?
Loading comments...